NRNP 6552 Exam 1 – 2026/2027- Edition Questions And
100% Verified Answers
Overview:
Covers foundational women’s health: contraception per CDC MEC, emergency
contraception, STI screening/treatment per CDC guidelines, cervical cancer screening per
USPSTF, vaginal infections, breast disorders, and early pregnancy care. Emphasizes
clinical decision-making, pharmacology, and ACOG/USPSTF evidence-based management
for reproductive-age patients. Correct answer in bold Green
1. 36yo female, smokes 1 ppd, BMI 31, wants contraception. Which is CDC MEC
Category 4?
A. Copper IUD
B. DMPA
C. Combined hormonal contraceptive
D. Levonorgestrel IUD
Rationale: Age ≥35 + ≥15 cigarettes/day = Cat 4 for CHCs due to MI/stroke risk.
2. Most effective emergency contraception up to 5 days?
A. LNG 1.5mg
B. Ulipristal 30mg
C. Copper IUD
D. Yuzpe method
Rationale: Copper IUD >99% effective and not affected by BMI or timing up to 120h.
3. Patient on rifampin for TB. Which contraceptive has decreased efficacy?
A. COCs
B. DMPA
C. Copper IUD
D. Nexplanon
Rationale: Rifampin induces CYP3A4, lowers estrogen/progestin levels. Non-
hormonal/depot ok.
4. USPSTF: When to start cervical cancer screening, average risk?
A. Age 18
B. Age 21
C. Age 25
D. At sexual debut
Rationale: Start at 21 regardless of sexual history per USPSTF 2018.
5. 30yo, Pap = ASC-US, HPV negative. Next step?
A. Colposcopy
B. Repeat Pap 1 year
C. Co-test in 5 years
D. HPV test in 6 months
Rationale: ASC-US/HPV- = return to routine screening interval.
, 6. CDC 1st-line for uncomplicated gonorrhea?
A. Azithromycin 2g PO
B. Doxycycline 100mg BID x7d
C. Ceftriaxone 500mg IM x1
D. Cefixime 400mg PO
Rationale: 2021 CDC: Ceftriaxone 500mg IM. Dual therapy no longer routine.
7. Wet mount: clue cells, +whiff, pH 5.0. Treatment?
A. Fluconazole 150mg
B. Metronidazole 500mg BID x7d
C. Ceftriaxone IM
D. Clindamycin cream only if pregnant
Rationale: BV per Amsel criteria. 7-day oral metronidazole preferred.
8. Painful genital ulcer, tender inguinal nodes. Culture neg for HSV. Likely?
A. Syphilis
B. Chancroid
C. LGV
D. Granuloma inguinale
Rationale: Painful, purulent ulcer = chancroid. Syphilis chancre is painless.
9. RPR 1:128. Last year treated for syphilis, RPR was 1:8. Interpretation?
A. Serofast
B. Adequate response
C. Reinfection or treatment failure
D. False positive
Rationale: 4-fold rise in titer = reinfection/failure. Retreat.
10. Pregnant patient with syphilis, PCN allergy. Management?
A. Doxycycline
B. Azithromycin
C. Desensitize and give penicillin
D. Ceftriaxone x10d
Rationale: Only PCN treats fetus. Desensitization required in pregnancy.
11. HPV types causing 70% of cervical cancer?
A. 6, 11
B. 16, 18
C. 31, 33
D. 42, 44
Rationale: 16/18 high-risk. 6/11 cause warts.
12. Chlamydia treatment in pregnancy?
A. Doxycycline
B. Azithromycin 1g PO
C. Levofloxacin
D. Ofloxacin
Rationale: Azithromycin 1g or amoxicillin safe. Doxy/fluoroquinolones contraindicated.
13. Recurrent HSV ≥6x/year. Best option?
A. Episodic valacyclovir
B. Suppressive acyclovir 400mg BID
C. Topical acyclovir
100% Verified Answers
Overview:
Covers foundational women’s health: contraception per CDC MEC, emergency
contraception, STI screening/treatment per CDC guidelines, cervical cancer screening per
USPSTF, vaginal infections, breast disorders, and early pregnancy care. Emphasizes
clinical decision-making, pharmacology, and ACOG/USPSTF evidence-based management
for reproductive-age patients. Correct answer in bold Green
1. 36yo female, smokes 1 ppd, BMI 31, wants contraception. Which is CDC MEC
Category 4?
A. Copper IUD
B. DMPA
C. Combined hormonal contraceptive
D. Levonorgestrel IUD
Rationale: Age ≥35 + ≥15 cigarettes/day = Cat 4 for CHCs due to MI/stroke risk.
2. Most effective emergency contraception up to 5 days?
A. LNG 1.5mg
B. Ulipristal 30mg
C. Copper IUD
D. Yuzpe method
Rationale: Copper IUD >99% effective and not affected by BMI or timing up to 120h.
3. Patient on rifampin for TB. Which contraceptive has decreased efficacy?
A. COCs
B. DMPA
C. Copper IUD
D. Nexplanon
Rationale: Rifampin induces CYP3A4, lowers estrogen/progestin levels. Non-
hormonal/depot ok.
4. USPSTF: When to start cervical cancer screening, average risk?
A. Age 18
B. Age 21
C. Age 25
D. At sexual debut
Rationale: Start at 21 regardless of sexual history per USPSTF 2018.
5. 30yo, Pap = ASC-US, HPV negative. Next step?
A. Colposcopy
B. Repeat Pap 1 year
C. Co-test in 5 years
D. HPV test in 6 months
Rationale: ASC-US/HPV- = return to routine screening interval.
, 6. CDC 1st-line for uncomplicated gonorrhea?
A. Azithromycin 2g PO
B. Doxycycline 100mg BID x7d
C. Ceftriaxone 500mg IM x1
D. Cefixime 400mg PO
Rationale: 2021 CDC: Ceftriaxone 500mg IM. Dual therapy no longer routine.
7. Wet mount: clue cells, +whiff, pH 5.0. Treatment?
A. Fluconazole 150mg
B. Metronidazole 500mg BID x7d
C. Ceftriaxone IM
D. Clindamycin cream only if pregnant
Rationale: BV per Amsel criteria. 7-day oral metronidazole preferred.
8. Painful genital ulcer, tender inguinal nodes. Culture neg for HSV. Likely?
A. Syphilis
B. Chancroid
C. LGV
D. Granuloma inguinale
Rationale: Painful, purulent ulcer = chancroid. Syphilis chancre is painless.
9. RPR 1:128. Last year treated for syphilis, RPR was 1:8. Interpretation?
A. Serofast
B. Adequate response
C. Reinfection or treatment failure
D. False positive
Rationale: 4-fold rise in titer = reinfection/failure. Retreat.
10. Pregnant patient with syphilis, PCN allergy. Management?
A. Doxycycline
B. Azithromycin
C. Desensitize and give penicillin
D. Ceftriaxone x10d
Rationale: Only PCN treats fetus. Desensitization required in pregnancy.
11. HPV types causing 70% of cervical cancer?
A. 6, 11
B. 16, 18
C. 31, 33
D. 42, 44
Rationale: 16/18 high-risk. 6/11 cause warts.
12. Chlamydia treatment in pregnancy?
A. Doxycycline
B. Azithromycin 1g PO
C. Levofloxacin
D. Ofloxacin
Rationale: Azithromycin 1g or amoxicillin safe. Doxy/fluoroquinolones contraindicated.
13. Recurrent HSV ≥6x/year. Best option?
A. Episodic valacyclovir
B. Suppressive acyclovir 400mg BID
C. Topical acyclovir
